Frontlight ResearchEarly access
Atrial fibrillation trials in Germany
47 of 62 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleMonotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Drug-eluting Stent Implantation
- Where
- Frankfurt am Main, Friedrichshafen
- Age
- 18 years and over
- People
- 3,010 worldwide
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT05955365 - No phaseTaking peoplePULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Intervention - Study
- Where
- Bad Oeynhausen, Cologne, Düsseldorf, Frankfurt, Giessen, Hamburg, Herne, Leipzig, Neuss, Nuremberg
- Age
- 18 years and over
- People
- 264
- Run by
- Asklepios proresearch
See details and how to joinNCT07621003 - Phase 3Not yet taking people in GermanyStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Where
- Berlin, Dresden, Halle (saale), Tuebingen, Wermsdorf
- Age
- 18 years and over
- People
- 2,628 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07430956 · EU 2025-521618-25-00 - No phaseTaking peopleEarly Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
- Where
- Berlin, Bonn, Göttingen, Hamburg, Heidelberg, Leipzig, Lübeck, Mannheim, Tübingen
- Age
- 18 years and over
- People
- 482 worldwide
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT05976685 - Phase 3Not yet taking people in GermanyStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Where
- Altenburg, Bonn, Dresden, Essen, Hagen, Halle (saale), Kaiserslautern, Minden, Tuebingen, Wermsdorf
- Age
- 18 years and over
- People
- 15,364 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07626411 · EU 2025-521617-97-00 - No phaseTaking peopleStructured Treatment and Resource Efficiency Assessment With Lean Six Sigma Integration for Pulmonary Vein Isolation
- Where
- Wiesbaden
- Age
- 18 years and over
- People
- 94
- Run by
- St. Josefs-Hospital Wiesbaden GmbH
See details and how to joinNCT07910370 - Phase 2Taking peopleA Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
- Where
- Bad Homburg, Berlin, Hamburg
- Age
- 18 years and over
- People
- 165 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07217067 - No phaseTaking peopleComprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration
- Where
- Berlin, Frankfurt am Main, Lübeck
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- Abbott Medical Devices
See details and how to joinNCT07523620 - Phase 2Taking peopleA Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
- Where
- Altenburg, Bad Oeynhausen, Bonn, Hanover
- Age
- 18 years to 85 years
- People
- 360 worldwide
- Run by
- Bayer
See details and how to joinNCT07625215 · EU 2025-523807-31-00 - Phase 2Taking peopleA study to investigate the efficacy, safety, tolerability and pharmacokinetics of PKN605 in participants with atrial fibrillation
- Where
- Bad Homburg, Berlin, Hamburg
- Age
- 18 years and over
- People
- 41 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-520518-79-00 - Phase 2Taking peopleClinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
- Where
- Coburg, Frankfurt Am Main, Hamburg
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Acesion Pharma
See details and how to joinNCT07267949 · EU 2025-521377-14-00 - No phaseTaking peopleLeft Bundle Branch Area Pacing (LBBAP) PMCF Study
- Where
- Bad Nauheim
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Abbott Medical Devices
See details and how to joinNCT07217392 - No phaseTaking peopleThe Fourth Left Atrial Appendage Occlusion Study
- Where
- Bad Oeynhausen, Berlin, Cologne, Darmstadt, Erfurt, Frankfurt am Main, Frankfurt Am Main, Hamburg, Heidelberg, Kaiserslautern, Karlsruhe, Leipzig, Lübeck, Rostock, Zwickau
- Age
- 18 years and over
- People
- 4,000 worldwide
- Run by
- Hamilton Health Sciences Corporation
See details and how to joinNCT05963698 - No phaseTaking peopleAlEX-DHF: Ablation and Exercise in Diastolic Heart Failure
- Where
- Munich
- Age
- 18 years to 99 years
- People
- 40
- Run by
- Technical University of Munich
See details and how to joinNCT06650995 - Phase 3Taking peopleThe Direct Oral Anticoagulation versus Vitamin K Antagonist after Cardiac Surgery (DANCE) Trial
- Where
- Bonn, Essen, Freiburg, Hamburg, Jena, Leipzig
- Age
- 18 years and over
- People
- 1,000
- Run by
- Hamilton Health Sciences Corporation
See details and how to joinNCT04284839 · EU 2023-504504-28-00 - No phaseNot yet taking people in GermanyCatheter Ablation for AF in Patients With Severe Mitral Regurgitation After Successful Transcatheter Mitral-Valve Repair
- Where
- Cologne, Frankfurt, Hamburg, Münster
- Age
- 18 years and over
- People
- 956
- Run by
- Atrial Fibrillation Network
See details and how to joinNCT07380932 - No phaseNot yet taking people in GermanySingle-Shot Versus Focal Dual-Energy Pulsed Field-Based Ablation for Atrial Fibrillation
- Where
- Herne
- Age
- 18 years and over
- People
- 268
- Run by
- Marien Hospital Herne
See details and how to joinNCT07783919 - No phaseNot yet taking people in GermanyAugmented Reality Aided Remote Access and Technical Support for Complex Ablation Procedures
- Where
- Lübeck
- Age
- 18 years and over
- People
- 60
- Run by
- University of Luebeck
See details and how to joinNCT07777042 - No phaseTaking peopleComparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.
- Where
- Bad Neustadt an der Saale, Berlin, Bielefeld, Brandenburg an der Havel, Burgau, Chemnitz, Coburg, Dortmund, Dresden, Erfurt, Erlangen, Frankfurt am Main, Halle, Hamburg, Ingolstadt, Jena, Kaiserslautern, Koblenz, Leipzig, Lübeck, Magdeburg, Mannheim, Pirna, Recklinghausen, Rosenheim, Rotenburg an der Fulda, Rüsselsheim am Main, Zwickau
- Age
- 18 years and over
- People
- 530 worldwide
- Run by
- Jena University Hospital
See details and how to joinNCT04298723 - Phase 3Taking peopleStudy to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Where
- Altenburg, Berlin, Dresden, Hamburg, Hanover, Konstanz, Ludwigshafen am Rhein, Ludwigshafen Am Rhein, Mainz, Markkleeberg, Paderborn, Schwerin
- Age
- 65 years and over
- People
- 2,500 worldwide
- Run by
- Anthos Therapeutics, Inc.
See details and how to joinNCT05712200 · EU 2023-503224-66-00 - Phase 2Taking peopleIntravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients
- Where
- Augsburg, Berlin, Bonn, Göttingen, Hamburg, Kiel, Mainz, Münster, Rostock, Stuttgart
- Age
- 18 years and over
- People
- 550
- Run by
- GCP-Service International West GmbH
See details and how to joinNCT06279793 - Phase 3Taking peopleAnticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- Where
- Aachen, Bad Nauheim, Berlin, Bonn, Duesseldorf, Frankfurt Am Main, Freiburg im Breisgau, Halle (Saale), Hamburg, Jena, Leipzig, Magdeburg, Munich, Oldenburg, Trier
- Age
- 18 years and over
- People
- 3,200 worldwide
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT04045665 · EU 2024-515924-35-00 - No phaseNot yet taking people in GermanyAV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation
- Where
- Gelsenkirchen, Mainz, München, Paderborn, Stade
- Age
- 18 years and over
- People
- 292 worldwide
- Run by
- University Medical Center Groningen
See details and how to joinNCT07604727 - Phase 4Not yet taking people in GermanyPersonalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation
- Where
- Tübingen
- Age
- 18 years to 110 years
- People
- 2,500 worldwide
- Run by
- St. Antonius Hospital
See details and how to joinNCT06168370 · EU 2023-504637-42-01 - Phase 3Taking peopleEarly Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
- Where
- Bad Neustadt A.D.Saale, Berlin, Bielefeld, Bonn, Cologne, Dresden, Erlangen, Essen, Frankfurt Am Main, Giessen, Halle (Saale), Hamburg, Hanover, Heidelberg, Kiel, Leipzig, Luebeck, Lueneburg, Mannheim, Marburg, Muenster, Munich, Neumuenster, Tuebingen, Ulm, Wuerzburg
- Age
- 18 years and over
- People
- 1,746 worldwide
- Run by
- Universitätsklinikum Hamburg-Eppendorf
See details and how to joinNCT05293080 · EU 2025-521260-35-00